Are there any cheaper generic versions of Platinib?

Pralsetinib is a drug used to treat RET non-small cell lung cancer (NSCLC ) and thyroid cancer targeted drugs, as a RET inhibitor, it helps control disease progression by inhibiting tumor growth caused by RET gene mutations. Despite its remarkable efficacy, the original drug Platinib is relatively expensive, especially in the Chinese market. Although it is already on the market, it has not yet been included in the medical insurance system. Common packaging specifications are 100mg 60 tablets and 100mg 120 tablets. The price can be as high as more than 20,000 yuan, and in some areas the price may even reach 60,000 yuan, making the treatment burden very heavy for patients.

In overseas markets, the price of platinib is even higher.60The price of 60 tablets fluctuates between about 40,000 to more than 100,000 yuan. Such high prices undoubtedly put heavy financial pressure on patients, especially when long-term medication is required. Due to the long treatment cycle of platinib, patients often need to pay a large amount of drug costs, which is a considerable burden for many patients. The high price makes it unaffordable for many patients who need platinib treatment, and despite its remarkable effectiveness, they still face financial barriers.

In order to help patients reduce their financial burden, the emergence of generic drugs provides another option. Generic drugs of Platinib have been developed in overseas markets. The ingredients of these generic drugs are similar to those of the original drug, and their efficacy has been verified. Taking the generic drugs produced in Laos as an example, the price of 120 generic platinib pills is about more than 3,000 yuan, which is much cheaper than the price of the original drug. This kind of generic drug not only has an advantage in price, but also has the same ingredients as the original drug, so it can provide patients with the same therapeutic effect as the original drug, making it an important choice for many patients.

However, despite the price advantages offered by generic drugs, patients still need to be cautious in their selection. First of all, since the generic version of platinib has not yet been officially approved in China, patients need to pay special attention to its source and quality when using it. When purchasing generic medicines, it is crucial to ensure that they come from legitimate sources and meet relevant quality standards. Patients should undergo treatment under the guidance of a doctor to ensure the safety and effectiveness of the treatment. In addition, patients should regularly conduct treatment effect evaluation and side effect monitoring according to the doctor's advice to ensure the smooth progress of the treatment process.

Reference materials:https://gavreto.com/